
HKSEHealthcareMedical - Pharmaceuticals
Latest quote
HK$0.08
−HK$0.001 · -1.23%
China Health Group Inc., an investment holding company, researches and develops drugs, bio drugs, natural drugs, and synthetic drugs in the People’s Republic of China. The company offers contracted pharmaceutical development and clinical research, and post market; and post launch market research, medical science, and medical market services. It also provides hospital management, clinical research and promotion, rehabilitation tourism, and specialty hospital services, as well as Wanquan cloud health services. In addition, the company offers pharmacodynamics and clinical research of drugs. China Health Group Inc. was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in January 2015. The company was founded in 1998 and is headquartered in Beijing, China.
Latest quote
HK$0.08
−HK$0.001 · -1.23%
China Health Group Inc., an investment holding company, researches and develops drugs, bio drugs, natural drugs, and synthetic drugs in the People’s Republic of China. The company offers contracted pharmaceutical development and clinical research, and post market; and post launch market research, medical science, and medical market services. It also provides hospital management, clinical research and promotion, rehabilitation tourism, and specialty hospital services, as well as Wanquan cloud health services. In addition, the company offers pharmacodynamics and clinical research of drugs. China Health Group Inc. was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in January 2015. The company was founded in 1998 and is headquartered in Beijing, China.
Day range
Current HK$0.08
52-week range
Current HK$0.08
Historical prices · Market data may be delayed.
China Health Group Inc., an investment holding company, researches and develops drugs, bio drugs, natural drugs, and synthetic drugs in the People’s Republic of China. The company offers contracted pharmaceutical development and clinical research, and post market; and post launch market research, medical science, and medical market services. It also provides hospital management, clinical research and promotion, rehabilitation tourism, and specialty hospital services, as well as Wanquan cloud health services. In addition, the company offers pharmacodynamics and clinical research of drugs. China Health Group Inc. was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in January 2015. The company was founded in 1998 and is headquartered in Beijing, China.
Day range
Current HK$0.08
52-week range
Current HK$0.08
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (CNY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 27.82M CNY | 26.45M CNY | 21.43M CNY | 13.09M CNY | 83.6M CNY |
| Cost of goods sold | 11.86M CNY | 16.39M CNY | 13.21M CNY | 7.35M CNY | 19.74M CNY |
| Gross profit | 15.97M CNY | 10.07M CNY | 8.21M CNY | 5.74M CNY | 63.86M CNY |
| Selling, general, and administrative | 30.42M CNY | 24.88M CNY | 65.54M CNY | 13.97M CNY | 14.43M CNY |
| Operating expenses | 30.42M CNY | 24.91M CNY | 65.54M CNY | 21.8M CNY | 21.77M CNY |
| Interest income | 68.19K CNY | 63K CNY | 116K CNY | 202K CNY | 430K CNY |
| Interest expense | — | — | — | 17K CNY | 15K CNY |
| Depreciation and amortization | 406.21K CNY | 606K CNY | 234K CNY | 151K CNY | 201K CNY |
| Operating income | −14.45M CNY | −14.85M CNY | −57.33M CNY | −16.06M CNY | 42.09M CNY |
| Net income | −14.57M CNY | −14.52M CNY | −58.01M CNY | −15.84M CNY | 36.33M CNY |
Company facts updated Sep 9, 2026.
Recent quarterly results
Recent quarterly results
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.